Loading...
Market
How many new partnerships will Septerna Inc. announce by December 31, 2024?
2
Resolution / Starting Odds
0 • 25%
1 • 25%
2-3 • 25%
4 or more • 25%
Official press releases from Septerna Inc.
Story
Goldman Sachs-backed Septerna Inc. Raises $288 Million in IPO, Valuation Reaches $970 Million After 31% Surge on Nasdaq Debut
Oct 25, 2024, 01:39 PM
Septerna Inc., a Goldman Sachs-backed biotechnology company, has successfully completed its upsized initial public offering (IPO), raising $288 million. The company offered 16 million shares at a price of $18 each, an increase from the previously proposed 15.27 million shares. Following its debut on the Nasdaq, Septerna's shares surged nearly 31%, leading to a market valuation of approximately $970 million. The IPO reflects positive investor sentiment in the biotech sector, particularly for companies focused on G protein-coupled receptors (GPCRs), which are crucial for developing new therapies. The funds raised will support Septerna's pipeline of GPCR drugs, addressing unmet patient needs.
View original story
Similar markets
Less than 5 partnerships • 25%
5 to 10 partnerships • 25%
11 to 20 partnerships • 25%
More than 20 partnerships • 25%
0-2 • 25%
3-5 • 25%
6-10 • 25%
More than 10 • 25%
0-5 • 25%
6-10 • 25%
11-20 • 25%
Over 20 • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
More than 8 • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
More than 8 • 25%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
More than 8 • 25%
0 new partnerships • 25%
1-2 new partnerships • 25%
3-4 new partnerships • 25%
5 or more new partnerships • 25%
0 - 2 partnerships • 25%
3 - 5 partnerships • 25%
6 - 8 partnerships • 25%
More than 8 partnerships • 25%
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
0-2 • 25%
3-5 • 25%
6-10 • 25%
More than 10 • 25%